DBL® Dexamethasone Sodium Phosphate
Country: New Zealand
Lingwa: Ingliż
Sors: Medsafe (Medicines Safety Authority)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Dexamethasone sodium phosphate 24 mg/mL
Disponibbli minn:
Pfizer New Zealand Limited
INN (Isem Internazzjonali):
Dexamethasone sodium phosphate 24 mg/mL
Dożaġġ:
120 mg/5mL
Għamla farmaċewtika:
Solution for injection
Kompożizzjoni:
Active: Dexamethasone sodium phosphate 24 mg/mL Excipient: Creatinine Disodium edetate dihydrate Hydrochloric acid Sodium citrate dihydrate Sodium hydroxide Water for injection
Unitajiet fil-pakkett:
Vial, glass, single dose, 1x5ml, 5 mL
Klassi:
Prescription
Tip ta 'preskrizzjoni:
Prescription
Manifatturat minn:
Sanofi Chimie
Sommarju tal-prodott:
Package - Contents - Shelf Life: Vial, glass, single dose, 1x5ml - 5 mL - 18 months from date of manufacture stored at or below 25°C protect from light
Data ta 'l-awtorizzazzjoni:
1984-09-20
